전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
t1/ 2 (h)
t1/2 (h)
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
half-life (t1/2)
halveringstijd (t1/2)
마지막 업데이트: 2014-11-21
사용 빈도: 1
품질:
elimination t1/2 (h)
eliminatie-t1/2 (uur)
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
t1/2 effective
t1/2 effectief
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
t1/2, hours
t½, uur
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
t1/2, minute§
t1/2, minuut§
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
t1/2 (hr) mean (s.d.), range
t1/2 (uur) mean (s.d.), bereik
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
the half-life (t1/2) in plasma is approximately 1.8 hours.
de halfwaardetijd (t½) in het plasma is ongeveer 1,8 uur.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
t1/2 range from cmax,ss to cmin,ss (day)
t1/2 spreiding van cmax,ss tot cmin,ss (dag)
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cu{\expndtw-2 rr}ent
stroom
마지막 업데이트: 2007-07-09
사용 빈도: 1
품질:
auc0-∞ (iu· h/ dl) t1/ 2 (h) adjusted recovery
tabel 2 – frequentie van bijwerkingen in klinisch onderzoek
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
the terminal elimination half- life (t1/2) is 5.4 hours.
de terminale eliminatiehalfwaardetijd (t½) is 5,4 uur.
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
the mean elimination half-life (t1/2) ranged from 8 to 16 hours.
de gemiddelde eliminatiehalfwaardetijd (t1/2) varieert van 8 tot 16 uur.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
pk parameter auc0-∞ (iu· h/ dl) t1/ 2 (h) adjusted recovery
pk-parameter auc0-∞ (ie· h/dl) t1/2 (h) aangepaste recovery (ie/dl/ie/kg) cmax (ie/dl)
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
the t1/2 of tocilizumab was concentration-dependent.
de t1/2 van tocilizumab was concentratieafhankelijk.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
alogliptin was eliminated with a mean terminal half-life (t1/2) of approximately 21 hours.
alogliptine werd geëlimineerd met een gemiddelde terminale halfwaardetijd (t1/2) van ongeveer 21 uur.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
mean plasma elimination half-life (t1/2) was 2.75 hours for the two dose groups.
de gemiddelde eliminatiehalfwaardetijd (t1/2) was 2,75 uur voor de twee doseringsgroepen.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
however, patients with positive neutralizing antibodies responses had decreased total clearance (cl) values and prolonged t1/2.
patiënten met positieve neutraliserende antistofreacties hadden echter lagere totale klaringswaarden (clearing, cl) en een verlengde t1/2.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
for liquids, gastric emptying t1/2 increased from 0.28 h to 0.69 h (p=0.0018).
voor vloeistoffen nam de halfwaardetijd van de maaglediging toe van 0,28 uur tot 0,69 uur (p = 0,0018).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
auc = area under the curve (fviii:c), t1/2 = terminal half-life,
auc = area under the curve (oppervlakte onder de curve) (fviii:c), t1/2 = halfwaardetijd,
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: